Insulet Change in Accounts Receivable 2010-2025 | PODD

Insulet change in accounts receivable for the twelve months ending June 30, 2025 was $-0.126B, a 35.29% decline year-over-year.

  • Insulet annual change in accounts receivable for 2024 was $-0.01B, a 93.26% decline from 2023.
  • Insulet annual change in accounts receivable for 2023 was $-0.154B, a 197.68% increase from 2022.
  • Insulet annual change in accounts receivable for 2022 was $-0.052B, a 27.35% decline from 2021.

Insulet Change in Accounts Receivable 2010-2025 | PODD

  • Insulet annual change in accounts receivable for 2024 was $-0.01B, a 93.26% decline from 2023.
  • Insulet annual change in accounts receivable for 2023 was $-0.154B, a 197.68% increase from 2022.
  • Insulet annual change in accounts receivable for 2022 was $-0.052B, a 27.35% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$228.8B
Boston Scientific (BSX)$156.9B
Stryker (SYK)$150.3B
EssilorLuxottica (ESLOY)$143.8B
Medtronic (MDT)$118.1B
Lonza Group Ag (LZAGY)$50B
Haleon (HLN)$43.5B
ResMed (RMD)$41.3B
GE HealthCare Technologies (GEHC)$33.9B
Agilent Technologies (A)$33.7B
Terumo (TRUMY)$26.9B
Koninklijke Philips (PHG)$26.7B
Zimmer Biomet Holdings (ZBH)$21.2B
Smith & Nephew SNATS (SNN)$16.3B
Baxter (BAX)$12.6B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$7.9B
Lantheus Holdings (LNTH)$3.9B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Prestige Consumer Healthcare (PBH)$3.3B
Perrigo (PRGO)$3.3B
ICU Medical (ICUI)$3.1B
Haemonetics (HAE)$2.7B
LeMaitre Vascular (LMAT)$2.2B
Curaleaf Holdings (CURLF)$2.1B
Acuren (TIC)$2.1B
QuidelOrtho (QDEL)$1.9B
Green Thumb Industries (GTBIF)$1.9B